Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacher disease

Ann Neurol. 1987 Feb;21(2):159-70. doi: 10.1002/ana.410210208.

Abstract

The brain of an 18-year-old patient with Pelizaeus-Merzbacher disease was examined by standard neuropathological and biochemical methods and by immunocytochemical and immunochemical techniques. Analysis revealed a lack of myelin-specific lipids, but showed a residual immunoreactivity for myelin basic protein, myelin-associated glycoprotein, and 2',3'-cyclic nucleotide-3'-phosphodiesterase. Examination by immunocytochemistry and enzyme-linked immunosorbent assay showed an absence of proteolipid apoprotein (lipophilin). The peripheral nervous system was normal. Pelizaeus-Merzbacher disease in humans shares many neuropathological and biochemical features with X-linked mutations in animals, e.g., the jimpy mouse and myelin-deficient rat. The specificity of this protein deficiency in Pelizaeus-Merzbacher disease gains additional support from the recent mapping of the lipophilin gene to the human X chromosome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Brain / metabolism
  • Brain / pathology
  • Central Nervous System / metabolism
  • Child
  • Diffuse Cerebral Sclerosis of Schilder / genetics
  • Diffuse Cerebral Sclerosis of Schilder / metabolism*
  • Diffuse Cerebral Sclerosis of Schilder / pathology
  • Histocytochemistry
  • Humans
  • Immunochemistry
  • Lipid Metabolism
  • Male
  • Myelin Proteins / metabolism
  • Myelin Sheath / metabolism
  • Nerve Tissue Proteins / biosynthesis*
  • Optic Nerve / metabolism
  • Pedigree
  • Proteolipids / biosynthesis*

Substances

  • Myelin Proteins
  • Nerve Tissue Proteins
  • Proteolipids